naturemary expands Calgary manufacturing to pursue women’s health R&D

Calgary-based naturemary is building a new Manufacturing & Innovation Hub to combine research, formulation, testing and commercial-scale production in Canada. The move is designed to support the company’s pain-relief business and speed development of next-generation products, with women’s health becoming a key focus.

Why it matters: - naturemary’s new Calgary hub is designed to keep more research, development and manufacturing in Canada. - The company is using its pain-relief business as a platform to build next-generation therapeutic products. - Women’s health, including hormonal transitions and associated pain, is becoming a larger part of naturemary’s innovation strategy. - The expansion reflects a broader push by Canadian companies to strengthen domestic production and reduce dependence on international manufacturing.

What happened: - Calgary-based naturemary is preparing to launch the naturemary Manufacturing & Innovation Hub in Calgary. - The facility will combine research and development, formulation, testing, quality processes and commercial-scale manufacturing under one roof. - The company is expanding beyond its existing pain-relief portfolio. - naturemary is also pursuing new retail, healthcare and international markets.

The details: - The company started with small-batch formulations developed by co-founder and CEO Sonia Kalra. - naturemary’s products now move through major pharmacy, grocery and natural-health distribution channels. - The company’s pain-relief products are supported by Canadian wholesale infrastructure that can serve retailers and pharmacies nationally. - The new hub will give naturemary more control over the path from early research and formulation to testing, manufacturing and commercialization. - The facility is expected to support research and development, formulation, product testing, quality control, regulatory support, pilot production and commercial manufacturing. - naturemary says the hub will also provide infrastructure to support select cosmetic and natural health product companies seeking Canadian formulation, research, quality and manufacturing capabilities. - The company is expanding its Canadian distribution platform and retail penetration across pharmacy, grocery, natural health and healthcare channels. - naturemary has begun pursuing international commercialization opportunities. - The company is building a pathway for products researched and developed in Canada to reach markets beyond North America.

Between the lines: - The company is shifting from being primarily a consumer brand to being a broader innovation platform. - Leadership is positioning Canadian scientific talent as an underused asset that can be tied more directly to commercialization. - Women’s health is a strategic category because pain, inflammation and hormonal change often overlap, but consumers still struggle to find products that fit changing needs. - The company’s focus on naturally derived compounds and formulation science suggests a product strategy aimed at differentiated therapeutic solutions, not just another wellness line.

What’s next: - naturemary plans to investigate new formulations and therapeutic approaches in women’s health. - The company will explore combinations, formulations and delivery approaches tied to pain and inflammation pathways. - The hub is intended to accelerate naturemary’s internal pipeline and support future commercialization. - The company expects Canadian R&D and manufacturing to remain central as it expands globally. - naturemary’s long-term goal is to develop products in Canada that can scale into internationally competitive businesses.

The bottom line: - naturemary is betting that building more of the innovation stack in Canada will help it move faster, control more of the product lifecycle and open a broader pipeline in women’s health.